As many as one out of 10 people age 60 and older will experience some kind of abuse, most often in the form of financial exploitation, says a new Cornell study.
The end of face masks in public could be a year or more away as questions of transmissibility post-vaccine and effectiveness against emerging strains remain. One thing is clear: when it comes to fit, function, fashion, and sustainability, current face masks leave a lot of room for improvement.
The key to curing multiple sclerosis may well lie in the mysterious signaling of lipids, a major component of cells, says Cornell chemist Jeremy Baskin.
The Cornell Institute for Food Systems Industry Partnership Program offers a new public-private partnership that brings together Cornell’s food science faculty and staff with industry scientists, engineers and leaders.
George Scangos '70, CEO of Biogen, one of the most valuable biotech companies in the country, discussed balancing the needs of Wall Street and patients during his lecture as the Robert S. Hatfield Fellow in Economic Education.
Years before COVID-19 turned into a global pandemic, biomolecular engineer Susan Daniel was already looking for ways to defeat it. Now she’s expanding her coronavirus studies, blending engineering with virology and data science.
Three pairs of early career scientists have been named the inaugural Mong Family Foundation Fellows in Neurotech. They will work jointly under the mentorship of faculty across Cornell to advance brain technologies.
To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.
With a $7.5 million gift from the Friedman Family Foundation, Weill Cornell Medicine has established a cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.